Innate Pharma (IPHA) EPS (Basic) (2019 - 2025)
Innate Pharma (IPHA) reported EPS (Basic) of -$85376.0 for Q2 2025, down 6.88% on a YoY basis from -$91679.1 in Q2 2024, and down 14467161.16% quarter-over-quarter from -$0.59 in Q4 2024.
Innate Pharma (IPHA) EPS (Basic) (2019 - 2025) Analysis & Trends
Innate Pharma has reported EPS (Basic) for 7 years, with the latest figure at -$85376.0 in Q2 2025.
- For the quarter ending Q2 2025, EPS (Basic) fell 6.88% year-over-year to -$85376.0; the trailing twelve-month figure through Dec 2025 stood at -$165260.5 (down 260.97% YoY), and the FY2025 full-year result was -$0.64, up 1.78% from the prior year.
- EPS (Basic) for Q2 2025 stood at -$85376.0, down from -$0.59 in the prior quarter.
- The five-year high for EPS (Basic) was $182550.0 in Q2 2023, with the low at -$85376.0 in Q2 2025.
- Historically, EPS (Basic) has averaged $4133.9 across 5 years, with a median of -$0.59 in 2024.
- Annual changes were most pronounced in 2021 — EPS (Basic) jumped 67790766.98% — and 2023, when it plunged 114617986.98%.
- Innate Pharma's EPS (Basic) stood at -$0.09 in 2021, then jumped by 100.0% to -$0.0 in 2022, then slumped by 114617986.98% to -$1.87 in 2023, then jumped by 68.47% to -$0.59 in 2024, then slumped by 14467161.16% to -$85376.0 in 2025.
- The last three EPS (Basic) figures came in at -$85376.0 (Q2 2025), -$0.59 (Q4 2024), and -$79883.9 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | 0.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -0.06 |
| 10 | Innate Pharma | 194.19 Mn | 194.19 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -85,376.00 |
| Dec 31, 2024 | -0.59 |
| Jun 30, 2024 | -79,883.87 |
| Dec 31, 2023 | -1.87 |
| Jun 30, 2023 | 182,550.00 |
| Dec 31, 2022 | 0.00 |
| Jun 30, 2022 | -912.50 |
| Dec 31, 2021 | -0.09 |
| Jun 30, 2021 | 20,830.00 |
| Dec 31, 2020 | -4,366.96 |
| Jun 30, 2020 | -0.03 |
| Dec 31, 2019 | -0.26 |